|
|
|
|
|
by thucydides
3712 days ago
|
|
Again, you make two claims here. 1: co-pays for Daraprim are very high. 2. Turing does not reimburse for those high co-pays. You're right about number 1. You cite no evidence for number 2. For its part, Turing says they reimburse for the high co-pays. Why wouldn't they? It would be a PR disaster not to reimburse, so it's manifestly in their interest. And they're making such a fat profit they can afford to reimburse people for high co-pays. Page 4 of the document you cited is just a list of examples of high co-pays. Yes. Again, where's the evidence that Turing does NOT reimburse for those co-pays? Do you have an example? |
|
From the memo I linked earlier:
> The email stated that the first patient “has a $6000.00 co-pay. She is not a Medicare part D but has a federal funded insurance plan so wouldn’t quali[f]y for co-pay assistance or be covered under whatever Medicare Part D plan you are working on right now with Turing.” The email stated that the second patient “has insurance, however her plan does not cover Daraprim. Attempted to transfer to UCB for free drug program but was advised that because she has insurance, she does not qualify. Free drug program is only for patients with no insurance.”
Basically, Turing says "sorry, you don't qualify". Turing denies people's claims repeatedly, because they just don't give a fuck. Not to mention the obvious problem of patients not being able to afford the co-pay, thereby having to go without the pills. I've clearly demonstrated that there are cases where patients cannot get the medicine they need as a direct consequence of the price hike. But hey, feel free to believe Turing is acting honorably because they want to protect their reputation. Believe whatever you want. I'm done here.
https://i.imgur.com/XBsKiFx.png